Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism
Top Cited Papers
- 1 June 2002
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 282 (6), F991-F997
- https://doi.org/10.1152/ajprenal.00283.2001
Abstract
Hyperuricemia is associated with hypertension and vascular disease, but whether this represents a causal relationship or an epiphenomenon remains unknown. We recently reported a model of mild hyperuricemia in rats that results in increased blood pressure and mild renal fibrosis. In this study, we examined the effect of hyperuricemia on the renal vasculature. Rats fed 2% oxonic acid and a low-salt diet for 7 wk developed mild hyperuricemia (1.8 vs. 1.4 mg/dl, P < 0.05), hypertension [147 vs. 127 mmHg systolic blood pressure (SBP), P < 0.05], and afferent arteriolar thickening, with a 35% increase in medial area (P < 0.05). Allopurinol or benziodarone prevented the hyperuricemia, hypertension, and arteriolopathy. Hydrochlorothiazide treatment did not prevent the hyperuricemia or arteriolopathy despite controlling blood pressure. In contrast, the arteriolopathy and hypertension were prevented by both enalapril and losartan. Uric acid also directly stimulated vascular smooth muscle cell proliferation in vitro, and this was partially inhibited by losartan. Thus hyperuricemia induces a renal arteriolopathy in rats that is blood pressure independent and involves the renin-angiotensin system.Keywords
This publication has 27 references indexed in Scilit:
- Tissue Angiotensin and Pathobiology of Vascular DiseaseHypertension, 2001
- Uric acid: is it a risk factor for cardiovascular disease?The American Journal of Cardiology, 2000
- Vascular remodelling of resistance vessels: can we define this?Cardiovascular Research, 1999
- IntroductionPublished by Springer Nature ,1998
- Effects of an Angiotensin-Converting Enzyme Inhibitor, a Calcium Antagonist, and an Endothelin Receptor Antagonist on Renal Afferent Arteriolar StructureHypertension, 1996
- Renal effects of angiotensin II receptor blockade in normotensive subjectsKidney International, 1996
- Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney modelKidney International, 1994
- Determinants of angiotensin II-induced hypertrophy versus hyperplasia in vascular smooth muscleDrug Development Research, 1993
- Does potassium supplementation lower blood pressure? A meta-analysis of published trialsJournal Of Hypertension, 1991
- Hypertensive vascular disease; description and natural historyJournal of Chronic Diseases, 1955